July 15, 2025HealthcareOpen Access

Developing a Patient Profile for the Detection of Cognitive Decline in Subjective Memory Complaint Patients: A Scoping Review and Cross-Sectional Study in Community Pharmacy

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Scoping review and cross-sectional study identify demographic factors and screening challenges in cognitive decline detection.

Community pharmacy-based screening for cognitive decline shows potential with a sensitivity of 0.707.
A scoping review revealed significant variability in screening practices across countries and communities.
Key demographic variables such as age and education are vital for identifying patients at risk for cognitive decline.
Implementation barriers limit the effectiveness of cognitive decline screening in community pharmacies.

Gil‐Peinado et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark